Evidence map›Paper›PMID 31362927›Full record

ArticleBlood advances2019

Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.

Xiaoyu Jiang, Xiaoqing Lu, Yu Zhang, Leda Lacaria, Brett J Schuchardt, David C Mikles, Marco Magistri, Idoia García-Ramírez, Isidro Sanchez-Garcia, Amjad Farooq and 4 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Lipid metabolism in B cell biology.Molecular oncology · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. FCRL1 Regulates B Cell Receptor-Induced ERK Activation through GRB2.Journal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 4 countries.

Xiaoyu JiangDivision of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.
Xiaoqing LuDivision of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.
Yu ZhangDivision of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.
Leda LacariaDepartment of Physics, University of Calabria, Rende, Italy.
Brett J SchuchardtDepartment of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL.
David C MiklesDepartment of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL.
Marco MagistriDivision of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.
Idoia García-RamírezExperimental Therapeutics and Translational Oncology Program, Instituto de Biología Moleculary Celular del Cáncer, Centro Superior de Investigaciones Científicas/Universidad de Salamanca and Institute of Biomedical Research of Salamanca, Salamanca, Spain; and.
Isidro Sanchez-GarciaExperimental Therapeutics and Translational Oncology Program, Instituto de Biología Moleculary Celular del Cáncer, Centro Superior de Investigaciones Científicas/Universidad de Salamanca and Institute of Biomedical Research of Salamanca, Salamanca, Spain; and.ORCID 0000-0001-6989-9905
Amjad FarooqDepartment of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL.
Ramiro E VerdunDivision of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.
Midhat H AbdulredaDiabetes Research Institute.ORCID 0000-0002-0146-5876
Vincent T MoyDepartment of Physiology and Biophysics, and.
Izidore S LossosDivision of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.ORCID 0000-0002-9346-9013
University of Miami · USUniversidad de Salamanca · ESUniversity of Calabria · IT

Funding

Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephen D. Nimer · 2019 to 2026
$24.1M
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCLR01CA233945 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LOSSOS, IZIDORE S, VERDUN, RAMIRO ERNESTO · 2019 to 2023
$1.8M
Structural and Functional Studies of the Novel DBD Domain of MKP5R01GM083897 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FAROOQ, AMJAD · 2008 to 2012
$1.6M
NCI NIH HHS P30 CA240139NCI NIH HHS R01 CA233945NIGMS NIH HHS R01 GM083897
6 · The paper itself

Abstract

Human germinal center (GC)-associated lymphoma (HGAL) is an adaptor protein expressed in GC B cells. HGAL regulates cell motility and B-cell receptor (BCR) signaling, processes that are central for the successful completion of the GC reaction. Herein, we demonstrate phosphorylation of HGAL by Syk and Lyn kinases at tyrosines Y80, Y86, Y106Y107, Y128, and Y148. The HGAL YEN motif (amino acids 107-109) is similar to the phosphopeptide motif pYXN used as a binding site to the growth factor receptor-bound protein 2 (Grb2). We demonstrate by biochemical and molecular methodologies that HGAL directly interacts with Grb2. Concordantly, microscopy studies demonstrate HGAL-Grb2 colocalization in the membrane central supramolecular activation clusters (cSMAC) following BCR activation. Mutation of the HGAL putative binding site to Grb2 abrogates the interaction between these proteins. Further, this HGAL mutant localizes exclusively in the peripheral SMAC and decreases the rate and intensity of BCR accumulation in the cSMAC. Furthermore, we demonstrate that Grb2, HGAL, and Syk interact in the same complex, but Grb2 does not modulate the effects of HGAL on Syk kinase activity. Overall, the interplay between the HGAL and Grb2 regulates the magnitude of BCR signaling and synapse formation.

Indexed as

Signal TransductionAnimalsB-LymphocytesCell LineGRB2 Adaptor ProteinIntracellular Signaling Peptides and ProteinsMiceMicrofilament ProteinsModels, BiologicalPhosphorylationProtein BindingReceptors, Antigen, B-Cellsrc-Family KinasesSyk KinaseGCSAM protein, humanGRB2 Adaptor ProteinGRB2 protein, humanIntracellular Signaling Peptides and Proteinslyn protein-tyrosine kinaseMicrofilament ProteinsReceptors, Antigen, B-Cellsrc-Family KinasesSyk KinaseSyk protein, mouse

Identifiers

PMID31362927
PMCPMC6693015
OpenAlexW2964920290

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.